Prenatal disruption of neocortical development alters prefrontal cortical neuron responses to dopamine in adult rats

Neuropsychopharmacology

Volumn 30, Issue 8, 2005, Pages 1426-1435

  Lavin, Antonieta ^a,b,c   Moore, Holly M ^a,b,d   Grace, Anthony A ^a,b  

^a UNIVERSITY OF PITTSBURGH SCHOOL OF MEDICINE   (United States)

^b UNIVERSITY OF PITTSBURGH   (United States)

^c MEDICAL UNIVERSITY OF SOUTH CAROLINA   (United States)

^d Och Spine at New York Presbyterian Hospitals   (United States)

Author keywords

Dopamine; Prefrontal cortex; Schizophrenia

Indexed keywords

DOPAMINE; METHYLAZOXYMETHANOL ACETATE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BRAIN CELL; BRAIN DEVELOPMENT; BRAIN ELECTROPHYSIOLOGY; CELL MEMBRANE DEPOLARIZATION; CONTROLLED STUDY; DOPAMINERGIC TRANSMISSION; ELECTROSTIMULATION; FEMALE; HIPPOCAMPUS; HYPERPOLARIZATION; IN VIVO STUDY; INTRACELLULAR RECORDING; LIMBIC SYSTEM; MALE; NEOCORTEX; NERVE CELL DIFFERENTIATION; NERVE CELL MEMBRANE POTENTIAL; NERVE CONDUCTION; NEWBORN; NONHUMAN; PREFRONTAL CORTEX; PRENATAL DEVELOPMENT; PRIORITY JOURNAL; RAT; SCHIZOPHRENIA; THALAMOCORTICAL TRACT;

ANIMALS; ANIMALS, NEWBORN; DOPAMINE; DRUG INTERACTIONS; ELECTRIC STIMULATION; FEMALE; MALE; MEMBRANE POTENTIALS; METHYLAZOXYMETHANOL ACETATE; NEURONS; PREFRONTAL CORTEX; PREGNANCY; PRENATAL EXPOSURE DELAYED EFFECTS; PROTEIN SYNTHESIS INHIBITORS; RATS; RATS, INBRED F344;

EID: 23844556524     PISSN: 0893133X     EISSN: None     Source Type: Journal    
DOI: 10.1038/sj.npp.1300696     Document Type: Article

References (89)

1. Akbarian S, Vinuela A, Kim JJ, Potkin SG, Bunney WE, Jones EG (1993). Distorted distribution of nicotinamide-adenine dinucleotide phospate-diaphorase neurons in temporal lobe of schizophrenics implies anomalous cortical development. Arch Gen Psychiatry 50: 178-187.
2. Akil M, Pierri JN, Whitehead RE, Edgar CL, Mohila C, Lewis DA (1999). Lamina-specific alterations in the dopamine innervation of the prefrontal cortex in schizophrenic subjects. Am J Psychiatry 156: 1580-1589.
3. Altshuler LL, Conrad A, Kovelman JA, Scheibel A (1987). Hippocampal pyramidal cell orientation in schizophrenia. A controlled neurohistologic study of the Yakovlev collection. Arch Gen Psychiatry 44: 1094-1098.
4. Andreasen NC, Swayze V, O'Leary DS, Nopolus P, Cizadlo T, Harris G et al (1995). Abnormalities in midline attentional circuitry in schizophrenia: evidence from magnetic resonance and positron emission tomography. Eur Neuropsychopharmacol 5(Suppl): 37-41.
5. Arnold SE, Franz BR, Gur RC, Shapiro RM, Moberg PJ, Trojanowski JQ (1995). Smaller neuron size in schizophrenia in hippocampal subfields that mediate cortical-hippocampal interactions. Am J Psychiatry 15: 738-748.
6. Banfi S, Dorigotti L, Abbracchio MP, Balduini W, Coen E, Ragusa C et al (1984). Methylazoxymethanol microencephaly in rats: neurochemical characterization and behavioral studies with the nootropic oxiracetam. Pharmacol Res Commun 161: 67-83.
7. Bayer VE, Towle AC, Pickel VM (1991). Ultrastrctural localization of neurotensin-like immunoreactivity within dense core vesicles in perikarya, but not terminalis, co-localizing tyrosine hydroxilase in the rat ventral tegmental area. J Comp Neurol 311: 176-196.
8. Berger B, Gasper P, Verney C (1991). Dopaminergic innervation of the cerebral cortex: unexpected differences between rodents and primates. Trends Neurosci 14: 21-27.
9. Berger B (1992). Dopaminergic innervation of the frontal cerebral cortex. Evolutionary trends and functional implications. Adv Neurol 57: 525-544.
10. Bernardi G, Cherubini E, Marciani MG, Mercuri N, Stanzione P (1982). Responses of intracellularly recorded cortical neurons to the iontophoretic application of dopamine. Brain Res 245: 262-274.
11. Bogerts B (1993). Recent advances in the neuropathology of Schizophrenia. Schizophrenia Bull 19: 431-445.
12. Bogerts B, Lieberman JA, Ashtari M, Bilder RM, Degreef G, Lerner G et al (1993). Hippocampus-amygdala volumes and psychopathology in chronic schizophrenia. Biol Psychiatry 33: 236-246.
13. Braff DL, Grillon C, Geyer MA (1992). Gating and habituation of the startle reflex in schizophrenic patients. Arch Gen Psychiatry 49: 206-215.
14. Breier A, Buchanan RW, Elkashef A, Munson RC, Kirpatrick B, Gellad F (1992). Brain morphology and schizophrenia. A magnetic resonance imaging study of limbic, prefrontal cortex and caudate structures. Arch Gen Psychiatry 49: 921-926.
15. Buchsbaum MS, Someya T, Teng CY, Abel L, Chin S, Najafi A et al (1996). PET and MRI of the thalamus in never-medicated patients with schizophrenia. Am J Psychiatry 153: 191-199.
16. Bunney BS, Aghajanian GK (1976). Dopamine and norepinephrine innervated cells in the rat prefrontal cortex: pharmacological differentiation using microiontophoretic techniques. Life Sci 19: 1783-1792.
17. Carter C, Robertson L, Nordahl T, Chaderjian M, Kraft L, O'ShoraCelaya L (1996). Spatial working memory deficits and their relationship to negative symptoms in unmedicated schizophrenia patients. Biol Psychiatry 40: 930-932.
18. Cattabeni F, Abbracchio MP, Cimnino M, Cocchi D, DiLuca M, Mennum Rosi F et al (1989). Methylazoxymethanol-induced microencephalia: persistent increase of cortical somatostanin-like immunoreactivity. Brain Res Dev 47: 156-159.
19. Chuhma N, Zhang H, Masson J, Zhuang X, Sulzer D, Hen R et al (2004). Dopamine neurons mediate a fast excitatory signal via their glutamatergic synapses. J Neurosci 24: 972-981.
20. Cowan RL, Sesack SR, Van Bockstaele EJ, Branchereau P, Chan J, Pickel V (1994). Analysis of synaptic inputs and targets of physiologically characterized neurons in rat frontal cortex: combined in vivo intracellular recording and immunolabeling. Synapse 17: 101-111.
21. Cowan RL, Wilson CJ (1994). Spontaneous firing patterns and axonal projections of single corticostriatal neurons in the rat medial agranular cortex. J Neurophysiol 71: 17-32.
22. Coyle JT (2004). The GABA-glutamate connection in schizophrenia: which is the proximate cause? Biochem Pharmacol 68: 1507-1514.
23. Daniel DG, Weinberger DR, Jones DW, Zigun JR, Coppola R, Handel S et al (1989). The effects of apomoprhine on regional cerebral flow in schizophrenia. J Neuropsychiatry 1: 377-384.
24. Daniel DG, Weinberger DR, Jones DW, Zigun JR, Coppola R, Handel S et al (1991). The effect of amphetamine on regional cerebral flow during cognitive activation in schizophrenia. J Neurosci 11: 1907-1917.
25. Descarries L, LeMay B, Doucet G, Berger B (1987). Regional and laminar density of the dopamine innervation in the adult rat cerebral cortex. Neuroscience 21: 807-824.
26. Domesick VB (1988). In: Kalivas PW, Nemeroff CB (eds). Neuroanatomical Organization of Dopamine Neurons in the Ventral Tegmental Area. New York Academy of Science: New York, p 537.
27. Flagstad P, Mork A, Glentoj BY, van Beek J, Micahel-Titus A, Didriksen S (2004). Disruption of neurogenesis on gestational day 17 in the rat causes behavioral changes relevant to positive and negative schizophrenia symptoms and alters amphetamine-induced dopamine release in nucleus accumbens. Neuropsychopharmacology 29: 2052-2064.
28. Perron A, Thierry AM, Le Dourain C, Glowinski J (1984). Inhibitory influence of the mesocortical dopaminergic system on spontaneous activity or excitatory response induced from the thalamic mediodorsal nucleus in the rat medial prefrontal cortex. Brain Res 302: 257-265.
29. Fuster JM (1990). Behavioral electrophysiology of the prefrontal cortex of the primate. Prog Brain Res 85: 313-322.
30. Geijo-Barrientos E, Pastore C (1995). The effects of dopamine on the subthreshold electrophysiological responses of rat prefrontal cortex neurons in vitro. Eur J Neurosci 7: 358-366.
31. Gigg J, Tan A M, Finch DM (1994). Glutamatergic hippocampal formation projections to prefrontal cortex in the rat are regulated by GABAergic inhibition and show convergence with glutamatergic projections from the limbic thalamus. Hippocampus 4: 189-198.
32. Glantz LA, Lewis DA (1997). Reduction of synaptophysin immunoreactivity in the prefrontal cortex of subjects with schizophrenia. Regional and diagnostic specificity. Arch Gen Psychiatry 54: 660-669.
33. Glantz LA, Lewis DA (2000). Decreased dendritic spine density on prefrontal cortical pyramidal neurons in schizophrenia. Arch Gen Psychiatry 57: 65-73.
34. Goldman-Rakic PS (1987). Circuitry of primate prefrontal cortex and regulation of behavior by representational memory. In: Plum E (ed) Handbook of Physiology. Vol V: Higher Functions of the Brain. American Physiological Society: Bethesda, MD. pp 373-417.
35. Goldman-Rakic PS, Leranth C, Williams SM, Mons N, Geffard M (1989). Dopamine synaptic complex with pyramidal neurons in primate cerebral cortex. Proc Natl Acad Sci USA 86: 9015-9019.
36. Gonzalez-Burgos G, Kroner S, Krimer LS, Seamans JK, Urban NN, Henze DA et al (2002). Dopamine modulation of neuronal function in the monkey prefrontal cortex. Physiol Behav 77: 537-543.
37. Gourevitch R, Rocher C, Le Pen G, Krebs MO, Jay TM (2004). Working memory deficits in adult rats after prenatal disruption of neurogenesis. Behav Pharmacol 15: 287-292.
38. Grace AA (1991). Phasic versus tonic dopamine release and the modulation of dopamine system responsivity: a hypothesis for the etiology of schizophrenia. Neuroscience 41: 1-24.
39. Grace AA (1993). Cortical regulation of subcortical dopamine systems and its possible relevance to schizophrenia. J Neural Transm 91: 111-134.
40. Grace AA (2000). Gating of information flow within the limbic system and the pathophysiology of schizophrenia. Brain Res Rev 31: 330-341.
41. Grace AA, Moore H, Lavin A (1998). Disruption of temporal cortical development as an animal model of schizophrenia: alterations in prefrontal cortical-limbic interactions. Int J Neuropsychopharmacol 1(Suppl 1): S24.
42. Gratton A, Hoffer BJ, Freedman R (1987). Electrophysiological effects of phencyclidine in the medial prefrontal cortex of the rat. Neuropharmacology 26: 1275-1283.
43. Gray JA, Joseph MH, Hemsley DR, Young AM, Warburton EC, Boulenguez P et al (1995). The role of mesolimbic dopaminergic and retrohippocampal afferents to the nucleus accumbens in latent inhibition: implications for schizophrenia. Behav Brain Res 71: 19-31.
44. Hokfelt T, Everitt BJ, Theodorsson-Norhedin E, Goldestein M (1984). Occurrence of neurotensin-like immunoreactivity in subpopulation of hypothalamic, mesencephalic and medullar cathecholamine neurons. J Comp Neurol 222: 543-559.
45. Holcomb HH, Cascella NG, Thaker GK, Medoff DR, Dannals RF, Tamminga CA (1996). Functional sites of neuroleptic drug action in the human brain: PET/FDG studies with and without haloperidol. Am J Psychiatry 153: 41-49.
46. Howard R, Mellers J, Petty R (1995). Magnetic resonance imaging volumetric measurements of the superior temporal gyrus, hippocampus, parahipocampal gyrus, frontal and temporal lobes in late paraphrenia. Psychol Med 25: 495-503.
47. Hunt PR, Aggleton JP (1991). Medial dorsal thalamic lesions and working memory in the rat. Behav Neural Biol 55: 227-246.
48. Itil T, Keskiner A, Kiremitici N, Holden JMC (1967). Effect of phencyclidine in chronic schizophrenics. Can J Psychiatry 12: 209-212.
49. Jay TM, Glowinski J, Thierry AM (1995). Inhibition of hippocampo-prefrontal cortex excitatory responses by the mesocortical DA system. Neuroreport 6: 1845-1848.
50. Johnston MV, Haddad R, Carman-Young A, Coyle JT (1982). Neurotransmitter chemistry of lissencephalic cortex induced in ferrets by fetal treatment with methylazoxymethanol acetate. Brain Res 256: 285-291.
51. Jones BE, Yang TZ (1985). The efferent projections from the reticular formation and the locus coeruleus studied by anterograde and retrograde axonal transport in the rat. J Comp Neurol 242: 56-92.
52. Katz M, Buchsbaum MS, Siegel Jr BV, Wu J, Haier RJ, Bunney Jr WE (1996). Correlational patterns of cerebral glucose metabolism in never-medicated schizophrenics. Neuropsychobiology 33: 1-11.
53. Lathi AC, Koffel B, Laporte D, Tamminga CA (1994). Subanesthetic doses of ketamine stimulate psychosis in schizophrenia. Neuropsychopharmacol 13: 9-19.
54. Laruelle M, Abi-Dargham A, Gil R, Kegles L, Innis R (1999). Increased dopamine transmission in schizophrenia: relationship to illness phases. Biol Psychiatry 46: 56-72.
55. Lavin A, Grace AA (1994). The modulation of dorsal thalamic cell activity by the ventral pallidum: its role in the regulation of thalamocortical activity by the basal ganglia. Synapse 18: 104-127.
56. Law-Tho D, Hirsch JC, Crepel F (1994). Dopamine modulation of synaptic transmission in rat prefrontal cortex: an in vitro electrophysiological study. Neurosci Res 21: 151-160.
57. Law-Tho D, Desce JM, Crepel F (1995). Dopamine favors the emergence of long-term depression versus long-term potentiation in slices of rat prefrontal cortex. Neurosci Lett 188: 125-128.
58. Le Moal M, Simon H (1991). Mesocortical dopaminergic network: functional and regulatory roles. Physiological Rev 71: 155-234.
59. Lewis BL, O'Donnell P (2000). Ventral tegmental area afferents to the prefrontal cortex maintain membrane potential 'Up' states in pyramidal neurons via D1 dopamine receptors. Cereb Cortex 10: 1168-1175.
60. Lipska BK, Chrapusta SJ, Egan MF, Weinberger DR (1995). Neonatal excitotoxic ventral hippocampal damage alters dopamine response to mild repeated stress and to chronic haloperidol. Synapse 20: 125-130.
61. Lipska BK, Jaskiw GE, Weinberger DR. (1993). Postpuberal emergence of hyper-responsiveness to stress and to amphetamine after neonatal damage: a potential animal model of schizophrenia. Neuropsycopharmacology 9: 67-75.
62. Malhotra AK, Pinals DA, Weingartner H, Sirocco K, Missar CD, Pickar D et al (1996). NMDA receptor function and human cognition: the effects of ketamine in healthy volunteers. Neuropsychopharmacology 14: 301-307.
63. Mercuri N, Calabresi P, Stanzione P, Bernardi G (1985). Electrical stimulation of mesencephalic cell groups (A9-A10) produces monosynaptic excitatory potentials in rat frontal cortex. Brain Res 338: 192-195.
64. Mohammed AK, Jonsson G, Sundstrom E, Minor BG, Soderberg U, Archer T (1986). Selective attention and place navigation in rats treated prenatally with methylazoxymethanol. Brain Res 395: 145-155.
65. Moore H, Ghajarnia M, Geyer M, Jentsch JD, Grace AA (2001). Selective disruption of prefrontal and limbic corticostriatal circuits by prenatal exposure to the DNA methylation agent methylazoxymethanol acetate (MAM): anatomical, neurophysiological and behavioral studies. Schizophrenia Res 49(S1-2): 2-48.
66. Mora F, Sweeney KF, Rolls ET, Sanguinetti AM (1976). Spontaneous firing rate of neurons in the prefrontal cortex of the rat: evidence for a dopaminergic inhibition. Brain Res 116: 516-522.
67. Norman RM, Malla AK (1993). Stressful life events and schizophrenia. I: a review of the research. Br J Psychiatry 162: 161-166.
68. O'Donnell P, Lewis BL, Weinberger DR, Lipska BK (2002). Neonatal hippocampal damage alters electrophysiological properties of prefrontal cortical neurons in adult rats. Cereb Cortex 12: 975-982.
69. Paxinos G, Watson C (1986). The Rat Brain in Stereotaxic Coordinates. Academic Press: San Diego, pp 1-83.
70. Pirot S, Godbout R, Mantz J, Tassin JP, Glowinski J, Thierry AM (1992). Inhibitory effects of ventral tegmental area stimulation on the activity of prefrontal cortical neurons: evidence for the involvement of both dopaminergic and GABAergic components. Neuroscience 49: 857-865.
71. Ray JP, Price JL (1992). The organization of the thalamocortical connections of the mediodorsal thalamic nucleus in the rat, related to the ventral forebrain-prefrontal cortex topography. J Comp Neurol 323: 167-197.
72. Satoh K, Fibiger HC (1986). Cholinergic neurons of the lateral tegmental nucleus: efferent and afferent connections. J Comp Neurol 253: 277-302.
73. Seamans JK, Nogueira L, Lavin A (2002). Synaptic basis of persistent activity in prefrontal cortex in vivo and in organotypic cultures. Cereb Cortex 13: 1242-1250.
74. Seamans JK, Yang CR (2004). The principal features and mechanisms of dopamine modulation in the prefrontal cortex. Prog Neurobiol 74: 1-57.
75. Shenton ME, Kikins R, Jolesz FA, Pollak SD, LeMay M, Wible CG et al (1992). Abnormalities of the left temporal lobe and thought disorder in schizophrenia. A quantitative magnetic resonance imaging study. N Engl J Med 327: 604-612.
76. Selemon LD, Rajkowska G, Goldman-Rakic P (1995). Abnormally high neuronal density in the schizophrenic cortex. Arch Gen Psychiatry 52: 805-818.
77. Sesack SR, Bunney BS (1989). Pharmacological characterization of the receptor mediating electrophysiological responses to dopamine in the rat medial prefrontal cortex: a microiontophoretic study. J Pharmacol Exp Ther 248: 1323-1333.
78. Siegel BV, Buchsbaum MS, Bunney Jr WE, Gottschalk LA, Haier RJ, Lohr JB et al (1993). Cortical-striatal-thalamic circuits and brain glucose metabolic activity in 70 unmedicated male schizophrenic patients. Am J Psychiatry 150: 1325-1336.
79. Steriade M, Nunez A, Amizca F (1993). A novel ( < 1 Hz) oscillation of neocortical neurons in vivo: depolarizing and hyperpolarizing components. J Neurosci 13: 3252-3266.
80. Stern EA, Kincaid AE, Wilson CJ (1997). Spontaneous subthreshold membrane potential fluctuations and action potential variability of rat corticostriatal and striatal neurons in vivo. J Neurophysiol 77: 1697-1715.
81. Tamminga CA, Thaker GK, Buchanan R, Kilpatrick B, Aphs LD, Chase TN et al (1992). Limbic system abnormalities identified in schizophrenia using positron emission tomography with fluorodeoxygluxose and neocortical alterations with deficit syndrome. Arch Gen Psychiatry 49: 522-530.
82. Thierry AM, Blanc M, Sobel A, Stinus L, Glowinski J (1973). Dopaminergic terminals in the rat cortex. Science 182: 499-500.
83. Timofeev I, Grenier F, Bazhenov M, Sejnowski TJ, Steriade M (2000). Origin of slow cortical oscillations in deafferented cortical slabs. Cereb Cortex 10: 1185-1199.
84. Yang CR, Seamans JK (1996). Dopamine D1 receptor actions on layer V-VI rat prefrontal cortex neurons in vitro. J Neurosci 16: 1922-1935.
85. Yang CR, Seamans JS, Gorelova N (1996). Electrophysiological and morphological properties of layer V-VI principal pyramidal cells in rat prefrontal cortex in vitro. J Neurosci 16: 1904-1921.
86. Yang CR, Seamans JK, Gorelova N (1999). Developing a neuronal model for the pathophysiology of schizophrenia based on the nature of electrophysiological actions of dopamine in the prefrontal cortex. Neuropsychopharmacology 21: 161-194.
87. Van Eden CG, Hoonerman EM, Bujis RM, Matthjssen MA, Geffard M, Uylings HB (1987). Immunocytochemical localization of dopamine in the prefrontal cortex of the rat at the light and electron microscopical level. Neuroscience 22: 849-862.
88. Weinberger DR, Berman KF, Suddath R, Torrey EF (1992). Evidence of a dysfunction of a prefrontal-limbic network in schizophrenia: a magnetic resonance imaging and regional cerebral blood flow study of discordant monozygotic twins. Am J Psychiatry 149: 890-897.
89. Weinberger DR, Lipska BK (1995). Cortical maldevelopment, antipsychotic drugs, and schizophrenia: a search for common ground. Schizophrenia Res 16: 87-110.